Design, Synthesis, and Evaluation of Multitarget-Directed Ligands Against Alzheimer's Disease Based on the Fusion of Donepezil and Curcumin.

Jun Yan,Jinhui Hu,Anqiu Liu,Lin He,Xingshu Li,Hui Wei

DOI: https://doi.org/10.1016/j.bmc.2017.02.048

IF: 3.461

2017-01-01

Bioorganic & Medicinal Chemistry

Abstract:By fusing donepezil and curcumin, a novel series of compounds were obtained as multitarget-directed ligands against Alzheimer's disease. Among them, compound 11b displayed potent acetylcholinesterase (AChE) inhibition (IC50=187nM) and the highest BuChE/AChE selectivity (66.3). Compound 11b also inhibited 45.3% Aβ1-42 self-aggregation at 20μM and displayed remarkable antioxidant effects. The metal-chelating property of compound 11b was elucidated by determining the 1:1 stoichiometry for the 11b-Cu(II) complex. The excellent blood-brain barrier permeability of 11b also indicated the potential for the compound to penetrate the central nervous system.